Loading...

Madrigal Pharmaceuticals, Inc.

MDGL•NASDAQ
Healthcare
Biotechnology
$512.39
$-6.35(-1.22%)
U.S. Market opens in 49h 27m

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Overview

Explore Madrigal Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap11.8B
P/E Ratio-40.17
EPS (TTM)$-12.86
ROE-0.44%
Fundamental Analysis

AI Price Forecasts

1 Month$465.73
3 Months$486.37
1 Year Target$519.32

MDGL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Madrigal Pharmaceuticals, Inc. (MDGL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.17, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $519.32.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -40.17 and a market capitalization of 11.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.22%
5-Day Change
-3.31%
1-Month Change
15.13%
3-Month Change
6.65%
6-Month Change
21.56%
Year-to-Date (YTD) Change
-12.01%
1-Year Change
60.16%
3-Year Change
67.51%
5-Year Change
286.13%
All-Time (Max) Change
61.05%

Contact Information

https://www.madrigalpharma.com
267 824 2827
Four Tower Bridge, West Conshohocken, PA, 19428

Company Facts

528 Employees
IPO DateFeb 6, 2007
CountryUS
Actively Trading

Frequently Asked Questions